EDGAR Filing Documents for 0001571049-15-009883

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001571049-15-009883

Filing Date

2015-12-09

Accepted

2015-12-09 17:22:48

Documents

Period of Report

2015-12-07

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	t1502913-x1_4.html	4
1	FORM 4	t1502913-x1_4.xml	4	4144
	Complete submission text file	0001571049-15-009883.txt		5766

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330

Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 151279077